Related references
Note: Only part of the references are listed.Cefiderocol versus high-dose, extended-infusion meropenem for the treatment of Gram-negative nosocomial pneumonia (APEKS-NP): a randomised, double-blind, phase 3, non-inferiority trial
Richard G. Wunderink et al.
LANCET INFECTIOUS DISEASES (2021)
Cefiderocol for extensively-drug resistant gram-negative bacterial infections: real-world experience from a case-series and review of the literature
Sandra Zingg et al.
Open Forum Infectious Diseases (2020)
Case Report: Successful Rescue Therapy of Extensively Drug-Resistant Acinetobacter baumannii Osteomyelitis With Cefiderocol
Michael Dagher et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
Cefiderocol: A Novel Agent for the Management of Multidrug-Resistant Gram-Negative Organisms
Janet Y. Wu et al.
INFECTIOUS DISEASES AND THERAPY (2020)
New Treatment Options against Carbapenem-Resistant Acinetobacter baumannii Infections
Burcu Isler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Cefiderocol versus imipenem-cilastatin for the treatment of complicated urinary tract infections caused by Gram-negative uropathogens: a phase 2, randomised, double-blind, non-inferiority trial
Simon Portsmouth et al.
LANCET INFECTIOUS DISEASES (2018)
In Vitro Activity of the Siderophore Cephalosporin, Cefiderocol, against a Recent Collection of Clinically Relevant Gram-Negative Bacilli from North America and Europe, Including Carbapenem-Nonsusceptible Isolates (SIDERO-WT-2014 Study)
Meredith A. Hackel et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2017)
The antibiotic pipeline for multi-drug resistant gram negative bacteria: what can we expect?
Matthew E. Falagas et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2016)
Colistin-Resistant Acinetobacter baumannii: Beyond Carbapenem Resistance
Zubair A. Qureshi et al.
CLINICAL INFECTIOUS DISEASES (2015)
Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings
Jonathan A. Otter et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2013)
Eighteen Years of Experience With Acinetobacter baumannii in a Tertiary Care Hospital
L. Silvia Munoz-Price et al.
CRITICAL CARE MEDICINE (2013)
A multidrug-resistant Acinetobacter baumannii outbreak in intensive care unit: Antimicrobial and organizational strategies
Guglielmo Consales et al.
JOURNAL OF CRITICAL CARE (2011)
The epidemiology and control of Acinetobacter baumannii in health care facilities
PE Fournier et al.
CLINICAL INFECTIOUS DISEASES (2006)
Share Paper
